Equities
RingCentral Stock Hits 52-Week High as Earnings, Analyst Upgrades Fuel Rally
RingCentral shares touched $78.21, up 153% over the past year, after Q2 earnings beat expectations and RBC Capital and Needham raised price targets to $85.
L3Harris Stock Drops to $244.75 Low Amid Earnings Beat and Investor Caution
L3Harris Technologies’ shares fell to a 52-week low of $244.75 despite strong second-quarter 2026 earnings, as concerns over future growth and capital spending weighed on investor sentiment.
Natera Hits Record $373.58 on Q2 Revenue Beat
Shares of the genetic testing firm surged to a record after second-quarter revenue topped forecasts, fueling a sharp rally.
Blackrock Muni Target Term stock hits 52-week low at 22.04 USD
Blackrock Muni Target Term share fell to a 52‑week low of 22.04 USD.
FDA Extends Fee Waivers for Jaguar Health’s Two Drugs
San Francisco-based Jaguar Health Inc. secured PDUFA and veterinary medicine fee waivers for two drugs, covering fiscal 2027.
Laredo Oil signs LOI for Argentina project using gravity drainage tech
Texas-based energy developer said it will evaluate deploying its proprietary Underground Gravity Drainage technology in selected Argentine fields.
CrowdStrike Stock Rises to All-Time High of $250.36 on AI Cybersecurity Optimism
Shares of the cybersecurity firm hit a record as analysts cite accelerating revenue growth and expanding demand for AI-driven security solutions.
Kroger outlines AI strategy at GroceryShop conference
Kroger presented its AI strategy at the GroceryShop conference, according to a company news release.
Zions Bancorporation ADR Hits 52-Week Low at $17.66
Shares of Zions Bancorporation drop to their lowest level in a year, extending a 20% annual decline while a P/E of 8.15 and dividend yield above 6% draw valuations attention.
Nasdaq hits a new record close powered by ongoing artificial intelligence trade momentum
The Nasdaq closed at a record high, driven by continued artificial intelligence trade momentum.
Analog Devices Sees Strong Growth Amid Cyclical Recovery
Analog Devices (ADI) highlighted robust revenue growth and strategic acquisitions at J.P. Morgan’s 2026 U.S. All Stars Conference, projecting further expansion in 2025 and beyond.
DAVIDsTEA Q2 Fiscal 2026: Canadian sales up 5.5%, gross margin hits record 61.9%
Revenue growth and improved margins offset U.S. sales decline and higher expenses, as the tea retailer expands its Canadian footprint and optimizes fulfillment costs.
Frankfurt Stocks Rebound as Oil Prices Retreat From Middle East Tensions
Falling crude eased inflation worries and lifted the DAX 0.6% to 25,739; the MDax gained 1.7% to 31,764 amid geopolitical developments and strong US tech gains.
US Stocks Expected to Hold Gains, Oil Price Support Seen
US stock indices are likely to maintain their gains from Monday, with falling oil prices providing support. The Nasdaq 100 is close to its record high, while the Dow Jones Industrial Average is expected to rise slightly.
European stocks climb as oil prices fall, M&A buzz lifts Evonik
Fallen crude prices and Middle East diplomacy boost European equities, while KI enthusiasm and takeover speculation add further gains.
On surges on buyback and guidance; US markets edge higher ahead of earnings
US futures opened narrowly; Swiss SMI rose 0.4%. On lifted 6% on a $1B buyback and 2029 revenue target of at least CHF 5.6bn.
FDA Approves Phase 2 Trial for Palisade Bio's Crohn's Disease Drug
Palisade Bio's PDE4 inhibitor prodrug, PALI-2108, advances to Phase 2 trial for moderate to severe Crohn's disease, with first patient dosing targeted for Q1 2027.
FDA Demands Survival Trial for Compass’ Tovecimig in BTC Cancer
Compass Therapeutics faces FDA push for an additional survival study before seeking approval of tovecimig in advanced biliary tract cancer, despite existing Phase 2/3 trial results.
Nativo Resources Reports Progress at Peru Gold Operations
The Perth-based explorer said surface sampling confirmed high-grade gold mineralization at its Bonanza mine and secured project finance for the La Patona processing plant in its half-year results.
Mizuho Ups Meta Price Target to $750, Sees Bull Case Playing Out
Mizuho analyst Lloyd Walmsley raises Meta's price target to $750, citing rapid growth of Muse AI agent and upcoming Meta Connect event as evidence of a bullish outlook.
Standard Chartered CEO Highlights Growth, AI Push Amid Caution at Bank of America Conference
Bill Winters outlines strategic priorities, including AI-driven efficiency and risk management, while maintaining income growth targets and operational resilience.
Aprea Therapeutics to present APR-1051 Phase 1 data at Barcelona symposium
Aprea Therapeutics (NASDAQ: APRE) will share interim Phase 1 results of its WEE1 inhibitor APR-1051 at the EORTC‑NCI‑AACR symposium in Barcelona on Nov 20, 2026.
Playtech COO Acquires 110,806 Shares via Options Exercise
Shimon Akad, COO of Playtech plc, exercised options to acquire 110,806 shares on September 17, 2024, under the Playtech Long Term Incentive Plan 2022.
Nuburu aims to close 70% Tekne acquisition by early October 2026
Nuburu announced it will acquire a controlling 70% stake in Italian defence firm Tekne S.p.A., targeting completion in early October 2026 after receiving Golden Power clearance and providing €7 million toward the €9 million closing requirement.